# Toast, Inc.: financial statements, quarterly TOST · NYSE · CIK 1650164 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/tost.md) · [Financials](/companies/tost/financials.md) · [Filings](/companies/tost/filings.md) · [Insiders](/companies/tost/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tost/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,032](/filings/0001650164-24-000383.md) | [1,036 d](/filings/0001650164-26-000057.md) | [1,075](/filings/0001650164-25-000177.md) | [1,242](/filings/0001650164-25-000290.md) | [1,305](/filings/0001650164-25-000341.md) | [1,338 d](/filings/0001650164-26-000057.md) | [1,337](/filings/0001650164-26-000114.md) | [1,550](/filings/0001650164-26-000164.md) | [1,633](/filings/0001650164-25-000341.md) | [1,633 d](/filings/0001650164-26-000057.md) | [1,630](/filings/0001650164-26-000114.md) | [1,908](/filings/0001650164-26-000164.md) | | Cost of revenue | $m | [806](/filings/0001650164-24-000383.md) | [810 d](/filings/0001650164-26-000057.md) | [826](/filings/0001650164-25-000177.md) | [956](/filings/0001650164-25-000290.md) | [983](/filings/0001650164-25-000341.md) | [1,005 d](/filings/0001650164-26-000057.md) | [991](/filings/0001650164-26-000114.md) | [1,158](/filings/0001650164-26-000164.md) | [1,201](/filings/0001650164-25-000341.md) | [1,210 d](/filings/0001650164-26-000057.md) | [1,183](/filings/0001650164-26-000114.md) | [1,392](/filings/0001650164-26-000164.md) | | Gross profit | $m | [226](/filings/0001650164-24-000383.md) | [226 d](/filings/0001650164-26-000057.md) | [249](/filings/0001650164-25-000177.md) | [286](/filings/0001650164-25-000290.md) | [322](/filings/0001650164-25-000341.md) | [333 d](/filings/0001650164-26-000057.md) | [346](/filings/0001650164-26-000114.md) | [392](/filings/0001650164-26-000164.md) | [432](/filings/0001650164-25-000341.md) | [423 d](/filings/0001650164-26-000057.md) | [447](/filings/0001650164-26-000114.md) | [516](/filings/0001650164-26-000164.md) | | Research and development | $m | [87.0](/filings/0001650164-24-000383.md) | [94.0 d](/filings/0001650164-26-000057.md) | [83.0](/filings/0001650164-25-000177.md) | [87.0](/filings/0001650164-25-000290.md) | [89.0](/filings/0001650164-25-000341.md) | [93.0 d](/filings/0001650164-26-000057.md) | [84.0](/filings/0001650164-26-000114.md) | [91.0](/filings/0001650164-26-000164.md) | [102](/filings/0001650164-25-000341.md) | [97.0 d](/filings/0001650164-26-000057.md) | [97.0](/filings/0001650164-26-000114.md) | [109](/filings/0001650164-26-000164.md) | | Operating income | $m | [(59.0)](/filings/0001650164-24-000383.md) | [(56.0) d](/filings/0001650164-26-000057.md) | [(56.0)](/filings/0001650164-25-000177.md) | [5.0](/filings/0001650164-25-000290.md) | [34.0](/filings/0001650164-25-000341.md) | [32.0 d](/filings/0001650164-26-000057.md) | [43.0](/filings/0001650164-26-000114.md) | [80.0](/filings/0001650164-26-000164.md) | [84.0](/filings/0001650164-25-000341.md) | [85.0 d](/filings/0001650164-26-000057.md) | [110](/filings/0001650164-26-000114.md) | [152](/filings/0001650164-26-000164.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [0.0](/filings/0001650164-24-000383.md) | [1.0 d](/filings/0001650164-26-000057.md) | [1.0](/filings/0001650164-25-000177.md) | [0.0](/filings/0001650164-25-000290.md) | [1.0](/filings/0001650164-25-000341.md) | [0.0 d](/filings/0001650164-26-000057.md) | [2.0](/filings/0001650164-26-000114.md) | [3.0](/filings/0001650164-26-000164.md) | [(1.0)](/filings/0001650164-25-000341.md) | [0.0 d](/filings/0001650164-26-000057.md) | [5.0](/filings/0001650164-26-000114.md) | [8.0](/filings/0001650164-26-000164.md) | | Net income | $m | [(31.0)](/filings/0001650164-24-000383.md) | [(36.0) d](/filings/0001650164-26-000057.md) | [(83.0)](/filings/0001650164-25-000177.md) | [14.0](/filings/0001650164-25-000290.md) | [56.0](/filings/0001650164-25-000341.md) | [32.0 d](/filings/0001650164-26-000057.md) | [56.0](/filings/0001650164-26-000114.md) | [80.0](/filings/0001650164-26-000164.md) | [105](/filings/0001650164-25-000341.md) | [101 d](/filings/0001650164-26-000057.md) | [126](/filings/0001650164-26-000114.md) | [154](/filings/0001650164-26-000164.md) | | Diluted EPS | $ per share | [(0.09)](/filings/0001650164-24-000383.md) | not reported | [(0.15)](/filings/0001650164-25-000177.md) | [0.02](/filings/0001650164-25-000290.md) | [0.07](/filings/0001650164-25-000341.md) | not reported | [0.09](/filings/0001650164-26-000114.md) | [0.13](/filings/0001650164-26-000164.md) | [0.16](/filings/0001650164-25-000341.md) | not reported | [0.20](/filings/0001650164-26-000114.md) | [0.26](/filings/0001650164-26-000164.md) | | Basic EPS | $ per share | [(0.06)](/filings/0001650164-24-000383.md) | not reported | [(0.15)](/filings/0001650164-25-000177.md) | [0.03](/filings/0001650164-25-000290.md) | [0.10](/filings/0001650164-25-000341.md) | not reported | [0.10](/filings/0001650164-26-000114.md) | [0.14](/filings/0001650164-26-000164.md) | [0.18](/filings/0001650164-25-000341.md) | not reported | [0.21](/filings/0001650164-26-000114.md) | [0.27](/filings/0001650164-26-000164.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [514](/filings/0001650164-24-000383.md) | [605](/filings/0001650164-26-000057.md) | [578](/filings/0001650164-25-000177.md) | [691](/filings/0001650164-25-000290.md) | [761](/filings/0001650164-25-000341.md) | [903](/filings/0001650164-26-000057.md) | [1,005](/filings/0001650164-26-000114.md) | [1,194](/filings/0001650164-26-000164.md) | [1,357](/filings/0001650164-25-000341.md) | [1,353](/filings/0001650164-26-000164.md) | [1,098](/filings/0001650164-26-000114.md) | [1,015](/filings/0001650164-26-000164.md) | | Current assets | $m | [1,480](/filings/0001650164-23-000369.md) | [1,570](/filings/0001650164-25-000072.md) | [1,651](/filings/0001650164-24-000177.md) | [1,739](/filings/0001650164-24-000283.md) | [1,802](/filings/0001650164-24-000383.md) | [1,975](/filings/0001650164-26-000057.md) | [2,122](/filings/0001650164-25-000177.md) | [2,317](/filings/0001650164-25-000290.md) | [2,495](/filings/0001650164-25-000341.md) | [2,669](/filings/0001650164-26-000164.md) | [2,592](/filings/0001650164-26-000114.md) | [2,650](/filings/0001650164-26-000164.md) | | Total assets | $m | [1,834](/filings/0001650164-23-000369.md) | [1,958](/filings/0001650164-25-000072.md) | [2,052](/filings/0001650164-24-000177.md) | [2,155](/filings/0001650164-24-000283.md) | [2,227](/filings/0001650164-24-000383.md) | [2,408](/filings/0001650164-26-000057.md) | [2,564](/filings/0001650164-25-000177.md) | [2,767](/filings/0001650164-25-000290.md) | [2,971](/filings/0001650164-25-000341.md) | [3,145](/filings/0001650164-26-000164.md) | [3,094](/filings/0001650164-26-000114.md) | [3,181](/filings/0001650164-26-000164.md) | | Current liabilities | $m | [574](/filings/0001650164-23-000369.md) | [663](/filings/0001650164-25-000072.md) | [713](/filings/0001650164-24-000177.md) | [736](/filings/0001650164-24-000283.md) | [748](/filings/0001650164-24-000383.md) | [811](/filings/0001650164-26-000057.md) | [844](/filings/0001650164-25-000177.md) | [894](/filings/0001650164-25-000290.md) | [911](/filings/0001650164-25-000341.md) | [969](/filings/0001650164-26-000164.md) | [1,064](/filings/0001650164-26-000114.md) | [1,104](/filings/0001650164-26-000164.md) | | Total liabilities | $m | [685](/filings/0001650164-23-000369.md) | [764](/filings/0001650164-25-000072.md) | [849](/filings/0001650164-24-000177.md) | [872](/filings/0001650164-24-000283.md) | [807](/filings/0001650164-24-000383.md) | [863](/filings/0001650164-26-000057.md) | [891](/filings/0001650164-25-000177.md) | [949](/filings/0001650164-25-000290.md) | [957](/filings/0001650164-25-000341.md) | [1,021](/filings/0001650164-26-000164.md) | [1,104](/filings/0001650164-26-000114.md) | [1,136](/filings/0001650164-26-000164.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,149](/filings/0001650164-24-000383.md) | [1,194](/filings/0001650164-26-000057.md) | [1,203](/filings/0001650164-25-000290.md) | [1,283](/filings/0001650164-25-000341.md) | [1,420](/filings/0001650164-25-000341.md) | [1,545](/filings/0001650164-26-000164.md) | [1,673](/filings/0001650164-26-000164.md) | [1,818](/filings/0001650164-26-000164.md) | [2,014](/filings/0001650164-25-000341.md) | [2,124](/filings/0001650164-26-000164.md) | [1,990](/filings/0001650164-26-000164.md) | [2,045](/filings/0001650164-26-000164.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [48.0 d](/filings/0001650164-24-000383.md) | [92.0 d](/filings/0001650164-26-000057.md) | [(20.0)](/filings/0001650164-25-000177.md) | [124 d](/filings/0001650164-25-000290.md) | [109 d](/filings/0001650164-25-000341.md) | [147 d](/filings/0001650164-26-000057.md) | [79.0](/filings/0001650164-26-000114.md) | [223 d](/filings/0001650164-26-000164.md) | [165 d](/filings/0001650164-25-000341.md) | [194 d](/filings/0001650164-26-000057.md) | [132](/filings/0001650164-26-000114.md) | [144 d](/filings/0001650164-26-000164.md) | | Capital expenditure | $m | [0.0 d](/filings/0001650164-23-000369.md) | [38.0 d](/filings/0001650164-26-000057.md) | [13.0](/filings/0001650164-25-000177.md) | [16.0 d](/filings/0001650164-25-000290.md) | [12.0 d](/filings/0001650164-25-000341.md) | [13.0 d](/filings/0001650164-26-000057.md) | [10.0](/filings/0001650164-26-000114.md) | [15.0 d](/filings/0001650164-26-000164.md) | [12.0 d](/filings/0001650164-25-000341.md) | [16.0 d](/filings/0001650164-26-000057.md) | [17.0](/filings/0001650164-26-000114.md) | [14.0 d](/filings/0001650164-26-000164.md) | | Share repurchases | $m | [0.0 d](/filings/0001650164-24-000383.md) | [0.0 d](/filings/0001650164-26-000057.md) | [4.0](/filings/0001650164-25-000177.md) | [32.0 d](/filings/0001650164-25-000290.md) | [20.0 d](/filings/0001650164-25-000341.md) | [0.0 d](/filings/0001650164-26-000057.md) | [17.0](/filings/0001650164-26-000114.md) | [14.0 d](/filings/0001650164-26-000164.md) | [23.0 d](/filings/0001650164-25-000341.md) | [53.0 d](/filings/0001650164-26-000057.md) | [323](/filings/0001650164-26-000114.md) | [163 d](/filings/0001650164-26-000164.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [514](/filings/0001650164-23-000369.md) | [525](/filings/0001650164-24-000177.md) | [529](/filings/0001650164-24-000283.md) | [536](/filings/0001650164-24-000383.md) | [547](/filings/0001650164-25-000177.md) | [587](/filings/0001650164-25-000290.md) | [590](/filings/0001650164-25-000341.md) | [603](/filings/0001650164-26-000114.md) | [605](/filings/0001650164-26-000164.md) | [609](/filings/0001650164-25-000341.md) | [602](/filings/0001650164-26-000114.md) | [590](/filings/0001650164-26-000164.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.